Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS

Published:2020-06 Issue:6 Volume:82 Page:1328-1336
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Silverberg Jonathan I.,Yosipovitch Gil,Simpson Eric L.,Kim Brian S.,Wu Jashin J.,Eckert Laurent,Guillemin Isabelle,Chen Zhen,Ardeleanu Marius,Bansal Ashish,Kaur Mandeep,Rossi Ana B.,Graham Neil M.H.,Patel Naimish,Gadkari Abhijit

Funder

Sanofi

Regeneron Pharmaceuticals, Inc

Sanofi Genzyme

Regeneron Pharmaceuticals

Kiniksa

LEO Pharma

Pfizer

Amgen

Anacor

Celgene

Chugai

Eli Lilly

Galderma

Genentech

GlaxoSmithKline

MedImmune

Novartis

Roivant

Tioga

Vanda

Publisher

Elsevier BV

Subject

Dermatology

Reference36 articles.

1. Th2 cytokines and atopic dermatitis;Brandt;J Clin Cell Immunol,2011

2. Epidemiology of atopic dermatitis: a review;DaVeiga;Allergy Asthma Proc,2012

3. Atopic dermatitis: global epidemiology and risk factors;Nutten;Ann Nutr Metab,2015

4. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study;Silverberg;J Allergy Clin Immunol,2013

5. Epidemiology of atopic dermatitis in adults: results from an international survey;Barbarot;Allergy,2018

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoklonale Antikörper für entzündliche, autoimmune und onkologische Hauterkrankungen;Die Dermatologie;2024-09-13

2. Stapokibart (CM310) targets IL-4Rα for the treatment of type 2 inflammation;iScience;2024-09

3. Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2);JAAD International;2024-09

4. Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis;Expert Opinion on Investigational Drugs;2024-08-21

5. Does Body Mass Index Impact the Clinical Response to Dupilumab Therapy in Atopic Dermatitis? A Monocentric Study of 170 Patients;Journal of Clinical Medicine;2024-08-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3